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Summary 1,3 Dimethylthiourea (DMTU) has previously been shown by us to inhibit the growth of
melanoma cells and to induce phenotypic alterations in these cells, including ultrastructural alterations of
mitochondria. These findings raised the possibility that impaired mitochondrial function might be involved in
mediating the effect of DMTU on cell growth and phenotypic expression. The present study indicates that
DMTU as well as another growth inhibitory methylurea derivative, tetramethylurea (TMU) significantly
decrease ATP content in the B16 melanoma cell line. 1,3 Dimethylurea (1,3DMU) and 1,1 dimethylurea
(l,lDMU) which are poor growth inhibitors, do not reduce ATP content significantly. Altered energy
metabolism in the DMTU-treated cells is reflected by inhibition of the activity ofcytochrome c oxidase and by
increased lactate levels. A cell line selected for resistance to growth inhibition by DMTU was shown to be
completely resistant to induction of phenotypic alterations by DMTU. These cells possess high lactate levels,
high ATP content and a somewhat decreased Na/K ATPase activity as compared to wild type B16 FIO cells.
1,3 DMTU treatment of the resistant cells leads to a decrease in the activity of the mitochondrial enzyme
cytochrome c oxidase, similar to its effect on the wild type B16 FIO cells. DMTU also reduces ATP content
moderately in the resistant cells. However, the levels of ATP do not decrease beyond those found in untreated
B16 FIO wild type cells. Taken together the results suggest that decreased ATP content might be involved, at
least partially, in mediating the effects of DMTU on B16 melanoma cell growth and phenotypic expression.
Dimethylthiourea (DMTU) is known as a relatively non
toxic free radical scavenger that prevents free radical medi-
ated damage in vitro and in vivo. Doses up to 1 gr kg-'
administered to sheep, rats and mice were reported to protect
animals from free radical mediated lung, kidney, heart and
brain injury (Fox, 1982, 1984; Paller et al., 1984; Bolli et al.,
1987; Morel et al., 1988; Martz et al., 1989). DMTU doses of
750 mg kg-', producing plasma concentrations of 10 mM,
prevented granulocyte mediated lung injury in sheep, without
altering normal neutrophil functions (Fox, 1984; Wong et al.,
1985). DMTU also inhibited the inflammatory response to
intravitreally injected endotoxin (Fleisher et al., 1989).
DMTU at a concentration of 10 mM was also shown to
interfere with DNA damage by a superoxide radical-generat-
ing system in Chinese hamster ovary cells (Hall et al., 1988).
Previous studies from our laboratory have revealed that
DMTU and TMU belong to a class of chemical agents that
can induce differentiated features in melanoma cells (Norden-
berg et al., 1985, 1987). The most known of them is dime-
thylsulfoxide that also shows free radical scavenging activity
(Nordenberg et al., 1986; Panganamal et al., 1976). Other
methylurea derivatives, TMU and 1,1DMU, were reported to
induce differentiation in Friend erythroleukaemic cells
(Preisler, 1976) and to oppose epidermal tumour promotion
in hamsters (McGaughey & Jensen, 1980). We have shown
that DMTU inhibits the proliferation of B16 FIO melanoma
cells in vitro. In vivo application of DMTU delays tumour
appearance in mice implanted with tumour cells (Nordenberg
et al., 1985). Growth inhibition by DMTU was accompanied
by induction of phenotypic alterations that partially reflect a
more differentiated phenotype (Nordenberg et al., 1985, 1987;
Malik et al., 1987). These phenotypic alterations included
morphological and ultrastructural changes, such as formation
of dendrite like appendages and marked development of the
endoplasmic reticulum. A significant increase in the activity
of the endoplasmic reticulum associated enzyme NADPH
cytochrome c reductase was also found. Transmission elec-
tron-microscopy of B16 F10 melanoma cells treated with
DMTU revealed swollen mitochrondria with disrupted cris-
tae (Malik et al., 1987). The mechanism of DMTU-induced
growth inhibition and induction of differentiation has not
been explored. The mitochondrial damage induced by
DMTU raised the possibility that an effect of DMTU in
reducing ATP level might be involved in mediating its anti-
proliferative and/or differentiating effects in the melanoma
cells. In the present study the effects of DMTU on ATP
content, lactate concentration and cytochrome c oxidase
activity were determined in B16 melanoma cells. In addition,
a cell line resistant to growth inhibition by DMTU (B16
DMTU/R) was selected and its sensitivity to induction of
phenotypic alterations and changes in ATP metabolism by
DMTU are described.
The results suggest that a decrease in ATP level might be
involved, at least partially, in mediating growth inhibition
and induction of phenotypic alterations by DMTU.
Materials and methods
Chemicals
1,3DMTU was obtained from Aldrich Chem. Comp. TMU,
1,3DMU and l,lDMU were obtained from Sigma Chem.
Comp. Reagents for biochemical analysis were purchased
from Sigma Chem. Comp. Tissue culture reagents were pur-
chased from Biol. Industries (Israel).
Cell line
B16 FIO mouse melanoma cells were grown in RPMI 1640
medium supplemented with 10% foetal calf serum. Culture
conditions were as described previously (Nordenberg et al.,
1985, 1986).
Selection ofa cell line resistant to growth-inhibition by DMTU
The selection method of a line resistant to growth inhibition
by DMTU was essentially as that described by Lotan et al.
(1983). However, no mutagen was used. Briefly, B16 FIO
melanoma cells (5 x 103) were cloned in semi solid agar in
the presence of 15 mM DMTU, as previously described
(Wasserman et al., 1987). Colonies were collected 14 days
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later and cells dispersed and grown as monolayers in the
presence of 15 mM DMTU in tissue culture bottles. This
procedure was repeated five times. After 8 months the sen-
sitivity of the cells to DMTU was examined.
nmoles cytochrome c oxidase min-'mg ' protein. Protein
content of the mitochondrial fraction was determined by the
method of Lowry et al. (1951), using bovine serum albumin
as a standard.
Cell growth experiments
For growth experiments, 5 x 104 cells were incubated in
0.5 ml growth medium with or without DMTU, TMU,
1,3DMU or 1,lDMU for 72 h in multiwell plates. Following
incubation, cells were detached with EDTA (1 mM) and
counted in a Coulter counter. Cell growth was expressed as
increase in cell number (cm2)-', following 72 h of incubation.
Clonogenic assay
B16 FIO wild type or DMTU-resistant melanoma cells (5 x
103) were plated in semi-solid agar in bacteriological dishes as
previously described (Wasserman et al., 1987) in the presence
or absence of DMTU, for 14 days. Colonies (clusters of more
than 30 cells) were counted with a phase microscope.
Examination ofphenotypic alterations
Determination of NADPH cytochrome c reductase and y
glutamyl transpeptidase activities: cells (106 10ml-') in 8.5
cm diameter plates were incubated for 72 h in the presence
and absence of 10 mM DMTU. NADPH cytochrome c
reductase activity was extracted and determined spectro-
photometically as previously described (Nordenberg et al.,
1987). Activity is expressed as nmoles acceptor reduced mg-1
DNA h-'. y Glutamyl transpeptidase activity was examined
on whole cells as previously described (Nordenberg et al.,
1987). Activity is expressed as nmoles product (p-nitro-
aniline) formed mg-1 DNA h-'.
Extraction and determination ofATP
Cells (5 x 104_-1 x I0 ml-') were incubated for 24 and 72h
in tissue culutre plates (8.5 cm diameter) in the presence and
absence of DMTU, TMU, 1,1DMU or 1,3DMU. For ATP
extraction, 3-5 x 106 were washed with ice-cold saline and
rapidly frozen in liquid nitrogen. ATP was extracted for
2 min with 0.5 ml ice-cold perchloric acid (7% v/v-'). The
lysates were neutralised with a mixture of KOH (1.5 M) and
KHCO3 (0.5 M) and centrifuged at 1,900g for 15 min at 4°C.
ATP was determined in the supernatants by the spectro-
fluorometric method described by Lowry et al. (1964). Sam-
ples for DNA determination were removed prior to the
addition of perchloric acid.
Determination ofDNA content
DNA content was measured by the fluorimetric method de-
scribed by Labarca and Paigen (1980), using calf thymus
DNA as a standard.
Extraction and determination ofcytochrome c oxidase activity
Cells (5 x 104- 1 x I05 ml-') were incubated for different time
intervals, in tissue culture plates (8.5 cm) in the absence and
presence of DMTU, TMU, 1,3DMU or l,lDMU. For ex-
traction ofcytochrome c oxidase, cells (7 x 106_ 1 x 107) were
washed with phosphate buffered saline (PBS), scraped with a
rubber policeman in PBS and collected by centrifugation at
600g for 7 min and then suspended in I ml Tris acetate
buffer (15 mM, pH 7.4), containing sucrose (250 mM), EDTA
(0.1 mM) and dithiothreitol (1 mM). Cells were disrupted by
three cycles of freezing and thawing. Nuclei were sedimented
by centrifugation at 400g at 4°C for 15 min. The super-
natants were centrifuged at 17,000g for 20 min at 4°C. The
sediment was suspended in 0.3 ml extraction buffer. Cyto-
chrome c oxidase was measured spectrophotometrically fol-
lowing the addition of deoxycholate (250 mM), as described
by Rubin and Tzagoloff (1978). Activity is expressed as
Lactate extraction and determination
Cells (5 x 104- 1 x 105ml-1) were incubated and extracted as
described above for ATP determination. Intracellular (cell
extracts) and extracellular (secreted to the growth medium
during 72 h) lactate was determined spectrophotometrically
as described by Gutmann and Wahlefeld (1974). One hun-
dred-200gAl cell extract, or 10 gAl medium were incubated for
30 min at 37°C in an assay mixture containing, glycine hyd-
razine buffer, pH 9.2, lactate dehydrogenase (12.5 U ml-')
and NAD (1.9 mM). NADH was measured spectrophotometri-
cally at 340 nm. Lactic acid (Sigma) was used as a standard
solution.
Determination ofNa/K ATPase activity
Cells were incubated in the presence or absence of 10mM
DMTU for 72 h. Na/K ATPase activity was determined by
measuring ouabain (2 mM) sensitive 86Rb influx as described
by Heller et al. (1987).
Results
The effects ofDMTU and chemically related compounds on
B16 FJO melanoma cellgrowth
We have previously shown the anti-proliferative effects of
DMTU and chemically related compounds on B16 mela-
noma cells (Nordenberg et al., 1985, 1987). The data in
Figure 1 summarise the effects of DMTU, TMU, 1,3DMU
and 1,1DMU on cell growth following 72 h incubation.
DMTU and TMU inhibited cell growth significantly. Cell
viability, however, was not decreased under these conditions,
as assessed by the trypan blue exclusion test. The growth
inhibitory effect of DMTU or TMU was reversible upon
removal of the compounds from the incubation medium
(data not shown). 1,3DMU has only a small inhibitory effect
on cell growth, whereas 1,lDMU does not significantly alter
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Figure 1 The effects of DMTU, TMU, 1,3DMU and l,lDMU
on B16 FI0 melanoma cell growth. Cells (8 x I03cm 2) were
incubated in 24-well plates in 0.5 culture medium in the absence
or presence of various concentrations of the indicated compounds
for 72 h. Cells were counted as described in Methods. Values are
means of 12 replicate± s.e. (vertical lines) done with four different
cell preparations.
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The effects ofDMTU and related derivatives on ATP content
ofB16 FJO melanoma cells
Intracellular ATP level is determined by its production and
ultilisation. The ultrastructural changes in mitochondria that
have previously been shown following DMTU treatment
(Malik et al., 1987), raised the possibility that DMTU might
interfere with respiratory function, leading to a decrease in
ATP content. The intracellular concentration of ATP was
determined in the B16 F10 melanoma cells following incuba-
tion of the cells with DMTU, TMU, 1,3DMU or l,lDMU
for 24 and 72 h. The results depicted in Figure 2 reveal that
DMTU and TMU significantly decreased the intracellular
ATP content in B16 FIO mouse melanoma cells. In contrast,
1,3DMU induced a slight, statistically not significant
decrease in ATP content and l,lDMU did not affect intracel-
lular ATP. The decrease in ATP following DMTU or TMU
treatment, occurred as early as 24 h following incubation.
Selection ofa cell line B16 DMTU/R resistant to growth
inhibition by DMTU
In order to get further insight into the relationship between
the anti-proliferative effect of DMTU and its effect on ATP
content, a cell line (B16 DMTU/R) resistant to growth inhi-
bition by DMTU was selected. B16 FIO melanoma cells were
selected for resistance to growth inhibition by repeated clon-
ing of cells in semi solid agar in the presence of 15 mM
DMTU. Colonies were isolated and grown in the presence of
15 mM DMTU for 8 months. After this period, sensitivity to
growth inhibition by DMTU was examined. Incubation of
the cells in the presence of DMTU (5, 10, 15, 20 mM)
resulted in complete growth inhibition by 30% and 55% at 5
and 10 mM DMTU, respectively. DMTU at 15 and 20 mM
inhibited the growth of the selected cell line by 12 and 28%
compared to 66% and 77% of the parent cell line. The B16
DMTU/R cells also showed partial resistance to growth
inhibition by TMU (5 and 10 mM TMU inhibited cell growth
by 17% and 28% compared to 42% and 73% for the parent
cells). The data presented in Table I show the effect of
various concentrations of DMTU on colony formation in
semi solid agar of B16 FIO wild type and of B16 DMTU/R
cell lines. DMTU markedly inhibited the ability of B16 FIO
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Figure 2 ATP content following incubation of B16 FIO mela-
noma cells in the presence of DMTU, TMU, 1,3DMU or
l,lDMU. Cells were incubated for 24 or 72h as described in
Methods. ATP was extracted and measured in the extracts as
described in Methods. Values are means of eight replicates done
with four different cell preparations. DMTU-treated vs untreated
(24 h) P<0.01; TMU-treated vs untreated (24 h) P<0.05;
DMTU, TMU-treated vs untreated (72h) P<0.01.
TableI TheeffectofDMTUonclonogenicityin semi solid agarofB16
FIO wild type and B16 DMTU/R cell lines
Number ofcolonies
Treatment B16 FO B16 DMTU/R
None 664±20 865± 32
DMTU (2.5 mM) 155±21 860± 26
DMTU (5 mM) 29±2 854±28
DMTU (10mM) 11±2 870±41
DMTU (15 mM) 811±18
Cells were plated as described in Methods in semi solid agar for 14
days in the presence or absence of various DMTU concentrations.
Values are means±s.e. for six replicates.
colony formation in DMTU/R cells. Growing the B16
DMTU/R cells in the absence of DMTU for over 1 month
maintained their resistance to growth inhibition by DMTU.
The stablility and genetic analysis of this mutant cell line are
currently under investigation in our laboratory.
Resistance ofB16 DMTU/R cell line to induction of
phenotypic alterations by DMTU
We have previously shown that increased NADPH cyto-
chrome c reductase, an enzyme associated with the endoplas-
mic reticulum follows the action of chemical inducers of
differentiation in melanoma cells (Fux et al., 1989). DMTU
as well as TMU also markedly enhanced the activity of this
enzyme (Nordenberg et al., 1987; Malik et al., 1987). The
results in Table II show that B16 DMTU/R cells were com-
pletely resistant to induction of an increase in the activity of
NADPH cytochrome c reductase by DMTU, in contrast to
B16 FIO cells.
DMTU also increased the activity of the plasma-mem-
brane bound enzyme ¶yglutamyl transpeptidase in the B16
FIO cells. DMTU had no effect on the activity of this enzyme
in B16 DMTU/R cells. The resistance to induction of these
phenotypic alterations by DMTU persisted also I month
after removal of DMTU from the growth medium.
The effect ofDMTU on ATP content in B16 DMTU/R cells
as compared to B16 FJO cells
The results in Figure 3 describe the effect of DMTU on ATP
content in B16 FIO wild type cells (a), in B16 DMTU/R cells
that were grown in the presence of DMTU for 8 months (b)
and in B16 DMTU/R cells that were grown for 8 months in
the presence of DMTU and 1 month without DMTU (c).
ATP content was determined 72 h following incubation of
the cells in the absence or presence of 10 mM DMTU. The
data demonstrate that B16 DMTU/R cells have higher levels
of ATP than B16 FIO wild type cells. Addition of DMTU to
these cells induced a smaller decrease in ATP content than
that in the wild type B16 F0 cells. ATP content in these cells
did not decline beyond the level found in the untreated wild
type B16 FIO cells.
The effect ofDMTU on cytochrome c oxidase activity and
lactate content in B16 FJO and B16 DMTU/R cells
ATP content is determined by the balance of its production
and utilisation. The main sources for ATP production are
mitochondrial respiration and glycolysis. Cytochrome c oxi-
dase was used in the studies of van den Bogert et al. (1983,
1986a,b), as a measure for functional mitochondrial capacity.
The data presented in Figure 4 show that both cell lines, B16
FIO and B16 DMTU/R have similar cytochrome c oxidase
activities, suggesting similar initial mitochrondrial capacity.
DMTU significantly inhibited the activity of cytochrome c
oxidase in the B16 FIO cells. Cytochrome c oxidase of B16
DMTU/R cells was found to keep its sensitivity to inhibiton
by DMTU.
In contrast to wild type B16 FlO cells, B16 DMTU/R cells
have originally high levels of lactate (Figure Sb). Lactate
levels were even higher 4 weeks following removal of DMTU492 A. FUX et al.
Table II The effect of DMTU on NADPH cytochrome c reductase and y glutamyl
transpeptidase activities in B16 FIO wild type and B16 DMTU/R cell lines
NADPH cyt. c. reductase y Glu. transpeptidase
nmoles mg-' DNA h ' pmoles mg-' DNA h-'
Cell line Untreated DMTU-treated Untreated DMTU-treated
B16 F1O 6.2±0.4 13.8±1.2c 3.6±0.5 7.5±1.0c
B16 DMTU/Ra 8.2± 1.7 6.8±0.6 3.8±0.8 2.9± 1.1
B16 DMTU/Rb 5.8±0.4 6.4±0.6 2.5±0.3 2.4±0.9
IB16 DMTU/R cells grown in the presence of DMTU for 8 months prior to the
experiment. bBl6 DMTU/R cells grown 8 months in thepresence ofDMTU and 1 month
in the absence of DMTU prior to the experiment. Values are means±s.d. for 6-15
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Figure 3 The effect of DMTU on ATP content of B16 DMTU/R
cell line as compared to B16 FIO wild type cells. Cells were
incubated in the presence or absence of DMTU (10mM) for
72 h. a, represents the B16 FI0 wild type cells. b, represents B16
DMTU/R cells which were grown for 8 months in the presence of
DMTU prior to ATP determination c, represents B16 DMTU/R
cells that were grown for 8 months in the presence of DMTU and
I month without DMTU prior to ATP determination. ATP was
determined as described in Methods. Values are means±s.e. of
12 replicates done with six different cell preparations. B16
DMTU/R (b,c untreated) vs B16 FIO (a) P<0.02. DMTU-
treated vs untreated of a P<0.001, of c P<0.01.
from the growth medium (Figure Sc). The B16 DMTU/R
cells also secrete about 3-fold more lactate to the culture
medium than the B16 FIO cells (Table III). The elevated
lactate content of B16 DMTU/R cells suggests that these
cells possess a higher glycolytic capacity than the B16 FIO
cells. Addition of DMTU to B16 DMTU/R cells only slightly
increased lactate content. In B16 FIO cells wild type cells,
DMTU markedly stimulated lactate formation (Figure 5a).
Determination ofNa/K ATPase activity in B16 FJO and B16
DMTU/R cells
Na/K ATPase is a major consumer of intracelluar ATP. Its
activity was measured in the wild type B16 FO0 and B16
DMTU/R cells in the absence and presence of DMTU. B16
DMTU/R cells were found to possess a 26% lower Na/K
ATPase activity than the parent B16 FIO cells (7.9 ± 0.9
nmoles 86Rb mg-' protein min-' for B16 DMTU/R cells, and
10.7 ± 0.6 nmoles 86Rb mg-' protein min-' for B16 FIO
parent cells, P<0.05). DMTU did not alter the activity of
this enzyme significantly, in either cell line.
Discussion
The present results show a correlation between the effect of





















Figure 4 Cytochrome C oxidase activity of untreated and
DMTU-treated B16 FIO and B16 DMTU/R cell lines. Cells were
incubated in the presence and absence of DMTU (1OmM) for
72 h. a, b, c as indicated in Figure 3. Enzyme activity was
measured as described in Methods. Values are means±s.e. of
8-12 replicates done with four separate cell preparations. DMTU
vs untreated of a and b, P<0.001 DMTU vs untreated of c,
P<0.05.
Figure 5 Lactate content of untreated and DMTU-treated B16
FIO and B16 DMTU/R cell lines. Cells were incubated in the
presence and absence of DMTU (10 mM). a, b, c as indicated in
Figure 2. Lactate was determined as described in Methods.
Values are means ± s.e. of 8-24 replicates done with 4-6 different
cell preparations. a DMTU vs untreated P<0.001. b, DMTU vs
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Table III Lactate secretion to the medium by B16 FIO and B16
DMTU/R cell lines
Lactate secretion
mg lactate secreted by mg DNA h-'
Treatment B16 FJO B16 DMTU/R
None 0.246±0.012 0.640±0.0IOa
DMTU 0.543±0.016a 0.608±0.028
Values aremeans±s.d. forthreeexperiments. IB16 DMTU/R vs B16
FIO and DMTU treated vs untreated B16 FIO. P<0.001.
ATP conent. DMTU and TMU which markedly inhibited
the growth of B16 melanoma cells, also induced a significant
decrease in ATP content. 1,3DMU, that only slightly inhib-
ited the growth of these cells showed only a small insigni-
ficant reduction in ATP content and 1,1DMU had neither an
effect on cell growth nor on ATP content. The finding that
ATP levels were already reduced 24 h following incubation of
the cells with DMTU or TMU may suggest that these com-
pounds have a primary effect on metabolic function leading
to decreased ATP content. Since our previous studies have
shown that DMTU alters mitochondrial ultrastructure and
the present data show an inhibitory effect on cytochrome c
oxidase activity following treatment of B16 melanoma cells
with DMTU, the mitochondria may be the target for the
action of DMTU. The sequence of events leading to mito-
chondrial damage and consequence reduction in ATP content
have to be further elucidated.
The B16 DMTU/R cells were prepared in order to get
some insight into the mechanism of DMTU-induced growth
inhibiton and induction of phenotypic alterations. the B16
DMTU/R cells possess initially higher levels ofATP than the
wild type B16 FIO cells. ATP content is determined by the
balance between its production and utilisation. The elevated
ATP content in B16 DMTU/R cells might be the result of
increased production or decreased utilitisation. Our results
favour the first possibility since B16 DMTU/R cells possess a
higher glycolytic capacity as demonstrated by the increased
intracellular lactate content and secretion. However, a reduc-
tion in ATP consuming reactions such as the observed some-
what lower Na/K ATPase activity of the B16 DMTU/R
might also contribute to the elevated ATP levels in the cells.
DMTU inhibited cytochrome c oxidase activity of both the
sensitive and resistant cell lines. However, the decrease in
ATP content induced in the resistant B16 DMTU/R cells was
smaller than that induced by DMTU in the wild type cells.
ATP level in the resistant cell line did not decline beyond
that found in untreated wild type B16 FIO cells. These
findings may suggest that in order to affect cell growth ATP
content has to decrease beyond a certain critical level. Alan-
osine, a compound leading to reduction of ATP due to
inhibition of the conversion of inosine monophosphate to
adenosine monophosphate was shown to inhibit rat hepa-
toma cell division when ATP concentration of the cells has
decreased by not more than 20% (Graff & Plagemann, 1976).
It has been reported that normal resting cells have large
reserve capacity for oxidative ATP generation as compared
to tumour cells (van den Bogert et al., 1983). This was also
demonstrated by the findings of Robins et al. (1985). showing
that dicarboxylic acids, azeleic and dodecanedioic are cyto-
toxic towards abnormally active and malignant human mela-
nocytes, but have no apparent effect upon melanocytes of
normal skin in vivos. These agents were shown to affect
markedly the ultrastructure of the mitochondria, as reflected
by massive swelling and destruction of cristae. Treatment of
solid cancer cells in vitro and in vivo with tetracyclines, that
are known as inhibitors of mitochondrial protein synthesis
inhibited the growth of different experimental tumours
(Kroon et al., 1984; van den Bogert et al., 1983, 1986a,b).
Tetracyclines were also shown to arrest Walker 256 tumour
in the Gl-phase of the cell cycle (van den Bogert et al.,
1986a), similarly to differentiating agents (Fallon & Cox,
1979).
The present findings show also a close correlation between
the decrease in ATP content and induction of phenoypic
alterations by DMTU. B16 DMTU/R cells that are resistant
to growth inhibition (Table I) and possess higher ATP levels
are also completely resistant to the DMTU induced increase
in the activities of NADPH cytochrome c reductase and y
glutamyltranspeptidase. Depletion of purine nucleotides has
been shown to induce cell differentiation in several cancer cell
types in vitro and in vivo (Weber et al., 1989). In view of the
multiple cellular functions linked to ATP and GTP utilisa-
tion, it is difficult to specify the sequence leading from a
decrease in the levels of one or both nucleotides to the
activation ofgenes leading to cell differentiation. Sokoloski et
al. (1989) have recently shown induction of differentation in
HL-60 cells by a novel agent, 5,10-dideazatetrahydrofolic
acid, that depletes ATP and GTP pools. These authors sug-
gested that it is possible that the induction of differentiation
by agents which deplete purine nucleotide pools may repre-
sent an adaptive response to 'metabolic stress'.
DMTU falls into the category of agents and modalities
which can elicit both, anti-proliferative and inductive differ-
entiating effects in cancer cells. This combination may be
advantageous for the development of new anti-tumour strat-
egies.
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